Katherine Pawlowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katherine Pawlowski has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Nicole Baumer
Children's Hospital Colorado
4 shared publications- Carol Lee Wilkinson
Division of Developmental Medicine, Boston Children's Hospital, Boston, MA
3 shared publications - Noemi Alice Spinazzi
Children’s Specialized Hospital, Robert Wood Johnson, Barnabas Health, Princeton, USA
3 shared publications Darren Olsen
Division of Developmental and Behavioral Health, Section of Psychology, Children’s Mercy University of Missouri ‐ Kansas City School of Medicine Kansas City Missouri USA
2 shared publications- Nicole T. Baumer
University of Colorado, Department of Pediatrics
2 shared publications - Anna Ba Milliken
Department of Psychology and Neuroscience, Baylor University, Waco, USA
1 shared publication
Latest Publications
- Open Access
- 19 October 2026
- Published by Wolters Kluwer Health in Journal of Developmental & Behavioral Pediatrics
Medical Conditions and Early Development in Toddlers With Down Syndrome
Objective: To examine the associations between medical conditions and early developmental skills in young children with Down syndrome (DS). Method: Data were drawn from the first timepoint of a longitudinal study of children with DS (n = 114; mean age = 20.6 months). Caregivers completed a comprehensive medical history questionnaire, followed by a structured interview and review by a medical doctor to clarify endorsed conditions. Cognitive, expressive, and receptive communication, and fine and gross motor developments were assessed using the Bayley Scales of Infant and Toddler Development, Fourth edition. Associations between medical condition categories and developmental skills across domains were examined using partial correlations adjusting for age. Dominance analyses assessed the unique contributions of significant medical categories. Results: Vision conditions were associated with lower developmental scores across cognitive, communication, and gross motor domains. Seizure/epilepsy was associated with lower cognitive, expressive communication, and motor domain scores. Length of neonatal intensive care unit stay was associated with lower cognitive and communication scores. Additional factors, including premature birth, structural gastrointestinal conditions, dysphagia, eczema, and thyroid disease, were associated with lower scores in specific developmental domains. Dominance analyses revealed overlapping contributions across significant predictors with each developmental domain. Conclusion: Findings highlight the associations between co-occurring medical conditions and developmental heterogeneity among young children with DS. Results underscore the need for further work, including longitudinal research studies, to clarify the role of medical conditions in shaping neurodevelopment in DS.
- 19 October 2026
- Published by Wolters Kluwer Health in Journal of Developmental & Behavioral Pediatrics
Open AccessMedical Conditions and Early Development in Toddlers With Down Syndrome
Objective: To examine the associations between medical conditions and early developmental skills in young children with Down syndrome (DS). Method: Data were drawn from the first timepoint of a longitudinal study of children with DS (n = 114; mean age = 20.6 months). Caregivers completed a comprehensive medical history questionnaire, followed by a structured interview and review by a medical doctor to clarify endorsed conditions. Cognitive, expressive, and receptive communication, and fine and gross motor developments were assessed using the Bayley Scales of Infant and Toddler Development, Fourth edition. Associations between medical condition categories and developmental skills across domains were examined using partial correlations adjusting for age. Dominance analyses assessed the unique contributions of significant medical categories. Results: Vision conditions were associated with lower developmental scores across cognitive, communication, and gross motor domains. Seizure/epilepsy was associated with lower cognitive, expressive communication, and motor domain scores. Length of neonatal intensive care unit stay was associated with lower cognitive and communication scores. Additional factors, including premature birth, structural gastrointestinal conditions, dysphagia, eczema, and thyroid disease, were associated with lower scores in specific developmental domains. Dominance analyses revealed overlapping contributions across significant predictors with each developmental domain. Conclusion: Findings highlight the associations between co-occurring medical conditions and developmental heterogeneity among young children with DS. Results underscore the need for further work, including longitudinal research studies, to clarify the role of medical conditions in shaping neurodevelopment in DS.
- Open Access
Altered early cortical EEG maturation and its relationship to language development in Down syndrome
Down syndrome (DS) is the most common genetic cause of intellectual disability, yet age-related cortical maturation patterns that contribute to developmental delays remain poorly understood. We analyzed longitudinal resting-state EEG and developmental data from 86 children with DS and 154 typically developing (TD) children between 12 and 81 months of age. Linear mixed-effect models tested age-related trajectories of aperiodic and periodic spectral features, and manifold learning was used to characterize multivariate EEG profiles associated with age and developmental ability. Children with DS showed altered maturation across multiple EEG features. Aperiodic exponent decreased with age in DS, but not TD children, indicating possible altered maturation of cortical excitability. While TD children showed expected age-related increases in theta-alpha peak frequency and amplitude, children with DS exhibited limited alpha maturation and greater persistence of theta-only and theta+alpha peak profiles. We next asked whether multivariate EEG organization reflected chronological maturation or individual differences in developmental ability. A spectral dimension associated with chronological age in TD children was not similarly age-associated in DS. Instead, a second spectral dimension was associated with verbal developmental quotient in children with DS, independent of chronological age and nonverbal developmental ability. This language-associated profile included features considered atypical relative to TD maturation, including increased aperiodic activity and continued presence of theta activity. These findings suggest that in DS there is an altered relationship between cortical spectral organization, chronological age, and language development, extending beyond a uniform delay in typical maturation.
Open AccessAltered early cortical EEG maturation and its relationship to language development in Down syndrome
Down syndrome (DS) is the most common genetic cause of intellectual disability, yet age-related cortical maturation patterns that contribute to developmental delays remain poorly understood. We analyzed longitudinal resting-state EEG and developmental data from 86 children with DS and 154 typically developing (TD) children between 12 and 81 months of age. Linear mixed-effect models tested age-related trajectories of aperiodic and periodic spectral features, and manifold learning was used to characterize multivariate EEG profiles associated with age and developmental ability. Children with DS showed altered maturation across multiple EEG features. Aperiodic exponent decreased with age in DS, but not TD children, indicating possible altered maturation of cortical excitability. While TD children showed expected age-related increases in theta-alpha peak frequency and amplitude, children with DS exhibited limited alpha maturation and greater persistence of theta-only and theta+alpha peak profiles. We next asked whether multivariate EEG organization reflected chronological maturation or individual differences in developmental ability. A spectral dimension associated with chronological age in TD children was not similarly age-associated in DS. Instead, a second spectral dimension was associated with verbal developmental quotient in children with DS, independent of chronological age and nonverbal developmental ability. This language-associated profile included features considered atypical relative to TD maturation, including increased aperiodic activity and continued presence of theta activity. These findings suggest that in DS there is an altered relationship between cortical spectral organization, chronological age, and language development, extending beyond a uniform delay in typical maturation.
- 8 May 2026
- Published by Wiley in Journal of Intellectual Disability Research
Practice Patterns and Barriers in the Assessment and Treatment of Autism Spectrum Disorder in Children With Down Syndrome
Background: Autism spectrum disorder (ASD) is common in individuals with Down syndrome (DS), with an estimated prevalence of 16%–18%. However, receiving a dual diagnosis of Down syndrome and ASD (DS + ASD) is often delayed. Little evidence exists on the path to ASD diagnosis nor interventions to support individuals with DS + ASD. Barriers to diagnosis and treatment for this unique patient population have yet to be described. This study explores clinicians' practices and perceptions regarding the diagnosis and treatment DS + ASD, and the barriers their patients face in connecting to recommended evaluations and services. Methods: The study used an anonymous web‐based survey developed by a group of physicians, psychologists and researchers who work with individuals with DS, ASD and DS + ASD. The survey queried clinicians from various specialties about their practice patterns regarding assessment of suspected ASD in individuals with DS. The survey inquired about treatment recommendations for DS + ASD and perceived barriers to connecting families with evaluations and services. Data analysis involved descriptive statistics and Mann–Whitney U tests. Results: Most respondents believe diagnosing ASD in individuals with DS significantly impacts management. Challenges were reported in accessing diagnostic evaluations, with heavy reliance on highly specialised DS and ASD clinics. Communication impairment ( n = 64, 65%), aggressive behaviours ( n = 38, 39%), self‐injurious behaviours ( n = 33, 34%) and adaptive skills ( n = 27, 28%) are priority targets for intervention, and applied behavioural analysis (ABA) ( n = 80, 82%), speech therapy through insurance ( n = 60, 61%), augmentative and alternative communication evaluation through insurance ( n = 59, 60%), and occupational therapy through insurance ( n = 57, 58%) are the most frequent referrals following a diagnosis of DS + ASD. All respondents identified multiple barriers to care for individuals with DS + ASD, including waitlists, insurance networks and requirements, lack of experienced providers and high turnover. Conclusion: This study highlighted the complexity of caring for individuals with DS + ASD, revealed the heterogeneity of practice patterns among providers, and reported multiple barriers to care for this underserved patient population. Results should prompt work aimed at redressing barriers to care and additional research in the field of effective interventions for individuals with DS + ASD.
- 8 May 2026
- Published by Wiley in Journal of Intellectual Disability Research
Practice Patterns and Barriers in the Assessment and Treatment of Autism Spectrum Disorder in Children With Down Syndrome
Background: Autism spectrum disorder (ASD) is common in individuals with Down syndrome (DS), with an estimated prevalence of 16%–18%. However, receiving a dual diagnosis of Down syndrome and ASD (DS + ASD) is often delayed. Little evidence exists on the path to ASD diagnosis nor interventions to support individuals with DS + ASD. Barriers to diagnosis and treatment for this unique patient population have yet to be described. This study explores clinicians' practices and perceptions regarding the diagnosis and treatment DS + ASD, and the barriers their patients face in connecting to recommended evaluations and services. Methods: The study used an anonymous web‐based survey developed by a group of physicians, psychologists and researchers who work with individuals with DS, ASD and DS + ASD. The survey queried clinicians from various specialties about their practice patterns regarding assessment of suspected ASD in individuals with DS. The survey inquired about treatment recommendations for DS + ASD and perceived barriers to connecting families with evaluations and services. Data analysis involved descriptive statistics and Mann–Whitney U tests. Results: Most respondents believe diagnosing ASD in individuals with DS significantly impacts management. Challenges were reported in accessing diagnostic evaluations, with heavy reliance on highly specialised DS and ASD clinics. Communication impairment ( n = 64, 65%), aggressive behaviours ( n = 38, 39%), self‐injurious behaviours ( n = 33, 34%) and adaptive skills ( n = 27, 28%) are priority targets for intervention, and applied behavioural analysis (ABA) ( n = 80, 82%), speech therapy through insurance ( n = 60, 61%), augmentative and alternative communication evaluation through insurance ( n = 59, 60%), and occupational therapy through insurance ( n = 57, 58%) are the most frequent referrals following a diagnosis of DS + ASD. All respondents identified multiple barriers to care for individuals with DS + ASD, including waitlists, insurance networks and requirements, lack of experienced providers and high turnover. Conclusion: This study highlighted the complexity of caring for individuals with DS + ASD, revealed the heterogeneity of practice patterns among providers, and reported multiple barriers to care for this underserved patient population. Results should prompt work aimed at redressing barriers to care and additional research in the field of effective interventions for individuals with DS + ASD.
- Open Access
- 25 March 2026
- Published by Wiley in Annals of the Child Neurology Society
- Vol. 4 (2) , 140-144
Developmental Milestones for Children With Down Syndrome: Revised Estimates Using Moving Average Summaries
Objective: Children with Down syndrome follow distinct developmental trajectories that require specialized monitoring and counseling. We aimed to provide updated estimates of developmental milestone attainment using a nonparametric approach and to compare these results with previously reported generalized linear mixed‐effects model (GLMM) estimates. Methods: We reanalyzed developmental data from 842 children with Down syndrome (ages 2 months to 24 years). For each milestone, achievement rates were calculated within overlapping 0.5‐year time windows, and shape‐constrained additive models were used to derive monotonic regression curves. Results: Compared with GLMM‐based estimates, the nonparametric approach predicted milestone attainment at least 1 year earlier for 17 of 25 milestones at the highest comparable percentile. Early gross motor milestones showed consistent achievement patterns across methods, whereas more complex adaptive, language, and academic skills demonstrated greater variability and were more sensitive to modeling assumptions. Females achieved 17 of 25 milestones at least 1 year earlier than males. Conclusions: These findings highlight substantial developmental heterogeneity and support the potential for continued skill acquisition throughout childhood and adolescence in individuals with Down syndrome. The updated estimates provide clinically relevant reference points to guide individualized monitoring, anticipatory guidance, and family counseling.
- 25 March 2026
- Published by Wiley in Annals of the Child Neurology Society
- Vol. 4 (2) , 140-144
Open AccessDevelopmental Milestones for Children With Down Syndrome: Revised Estimates Using Moving Average Summaries
Objective: Children with Down syndrome follow distinct developmental trajectories that require specialized monitoring and counseling. We aimed to provide updated estimates of developmental milestone attainment using a nonparametric approach and to compare these results with previously reported generalized linear mixed‐effects model (GLMM) estimates. Methods: We reanalyzed developmental data from 842 children with Down syndrome (ages 2 months to 24 years). For each milestone, achievement rates were calculated within overlapping 0.5‐year time windows, and shape‐constrained additive models were used to derive monotonic regression curves. Results: Compared with GLMM‐based estimates, the nonparametric approach predicted milestone attainment at least 1 year earlier for 17 of 25 milestones at the highest comparable percentile. Early gross motor milestones showed consistent achievement patterns across methods, whereas more complex adaptive, language, and academic skills demonstrated greater variability and were more sensitive to modeling assumptions. Females achieved 17 of 25 milestones at least 1 year earlier than males. Conclusions: These findings highlight substantial developmental heterogeneity and support the potential for continued skill acquisition throughout childhood and adolescence in individuals with Down syndrome. The updated estimates provide clinically relevant reference points to guide individualized monitoring, anticipatory guidance, and family counseling.
- 15 July 2025
- Published by Wiley in Journal of Intellectual Disability Research
Neurobehavioural Patterns in the Diagnosis of Autism Spectrum Disorder in Down Syndrome
Background: Autism spectrum disorder (ASD) is common in Down syndrome (DS). There are no standardised screening/assessment tools for evaluating ASD in DS.Methods: We utilised a novel validated questionnaire, the ND‐PROM, to investigate differences in developmental skills and behaviours among children with DS only, ASD only and DS + ASD.Results: Data analysis using ANOVA tests and post hoc t‐tests revealed item‐level differences between groups in domains specific to ASD (nonverbal communication, social–emotional understanding, social interaction, independent play, restrictive and repetitive behaviours and interests and sensory processes) and not specific to ASD (expressive language, receptive language, adaptive/toileting, challenging behaviours, mental health and impulse/ADHD).Conclusion: ASD‐specific symptoms best distinguished DS only and DS + ASD groups, while non‐ASD symptoms best distinguished ASD only and DS + ASD groups. Items that best differentiate groups are presented.
- 15 July 2025
- Published by Wiley in Journal of Intellectual Disability Research
Neurobehavioural Patterns in the Diagnosis of Autism Spectrum Disorder in Down Syndrome
Background: Autism spectrum disorder (ASD) is common in Down syndrome (DS). There are no standardised screening/assessment tools for evaluating ASD in DS.Methods: We utilised a novel validated questionnaire, the ND‐PROM, to investigate differences in developmental skills and behaviours among children with DS only, ASD only and DS + ASD.Results: Data analysis using ANOVA tests and post hoc t‐tests revealed item‐level differences between groups in domains specific to ASD (nonverbal communication, social–emotional understanding, social interaction, independent play, restrictive and repetitive behaviours and interests and sensory processes) and not specific to ASD (expressive language, receptive language, adaptive/toileting, challenging behaviours, mental health and impulse/ADHD).Conclusion: ASD‐specific symptoms best distinguished DS only and DS + ASD groups, while non‐ASD symptoms best distinguished ASD only and DS + ASD groups. Items that best differentiate groups are presented.
- 5 July 2024
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 35 (4) , 249-254
Psychotropic Medication Prescription Patterns in Down Syndrome in a Large Pediatric Specialty Clinic
Objectives: Patterns of psychotropic medication use in children and adolescents with Down syndrome (DS) are largely unknown. Clinical decisions are often made from evidence and experience from individuals with autism spectrum disorder (ASD) or intellectual disability (ID). Methods: Longitudinal data from 670 children with DS who received care in a specialty DS clinic from March 2021 to February 2024 were collected. After each clinic visit, the clinician indicated the presence or absence of co-occurring neurodevelopmental (ND) or mental health (MH) diagnoses, as well as whether the individual was prescribed a psychopharmacological treatment. We used descriptive statistics and analyzed associations between psychotropic medication use, co-occurring ND/MH conditions, and demographic data. Results: 19.1% of patients were prescribed at least one psychotropic medication at their most recent clinical visit. Alpha-agonists were the most commonly prescribed medication class (30.8%), followed by stimulants (18.9%), and antidepressants (16.7%). There was a significant difference in psychotropic medication use by age, with older children having increased odds of being prescribed a psychotropic medication. There were no differences in psychotropic medication use across sex ( p = 0.10), race ( p = 0.10), or household income ( p = 0.16). Conclusions: We found that one-fifth of patients with DS were prescribed psychotropic medications. Nearly every individual with DS who was prescribed a psychotropic medication had a co-occurring ND/MH condition, yet these rates were lower than what have been reported in children with ID, ASD, and attention deficit/hyperactivity disorder. Further research needs to include those with DS to further understand medication efficacy and safe dosing practices to ensure optimal outcomes.
- 5 July 2024
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 35 (4) , 249-254
Psychotropic Medication Prescription Patterns in Down Syndrome in a Large Pediatric Specialty Clinic
Objectives: Patterns of psychotropic medication use in children and adolescents with Down syndrome (DS) are largely unknown. Clinical decisions are often made from evidence and experience from individuals with autism spectrum disorder (ASD) or intellectual disability (ID). Methods: Longitudinal data from 670 children with DS who received care in a specialty DS clinic from March 2021 to February 2024 were collected. After each clinic visit, the clinician indicated the presence or absence of co-occurring neurodevelopmental (ND) or mental health (MH) diagnoses, as well as whether the individual was prescribed a psychopharmacological treatment. We used descriptive statistics and analyzed associations between psychotropic medication use, co-occurring ND/MH conditions, and demographic data. Results: 19.1% of patients were prescribed at least one psychotropic medication at their most recent clinical visit. Alpha-agonists were the most commonly prescribed medication class (30.8%), followed by stimulants (18.9%), and antidepressants (16.7%). There was a significant difference in psychotropic medication use by age, with older children having increased odds of being prescribed a psychotropic medication. There were no differences in psychotropic medication use across sex ( p = 0.10), race ( p = 0.10), or household income ( p = 0.16). Conclusions: We found that one-fifth of patients with DS were prescribed psychotropic medications. Nearly every individual with DS who was prescribed a psychotropic medication had a co-occurring ND/MH condition, yet these rates were lower than what have been reported in children with ID, ASD, and attention deficit/hyperactivity disorder. Further research needs to include those with DS to further understand medication efficacy and safe dosing practices to ensure optimal outcomes.
- Open Access
Alterations in aperiodic and periodic EEG activity in young children with Down syndrome
Down syndrome is the most common cause of intellectual disability, yet little is known about the neurobiological pathways leading to cognitive impairments. Electroencephalographic (EEG) measures are commonly used to study neurodevelopmental disorders, but few studies have focused on young children with DS. Here we assess resting state EEG data collected from toddlers/preschoolers with DS (n=29, age 13-48 months old) and compare their aperiodic and periodic EEG features with both age-matched (n=29) and cognitive-matched (n=58) comparison groups. DS participants exhibited significantly reduced aperiodic slope, increased periodic theta power, and decreased alpha peak amplitude. A majority of DS participants displayed a prominent peak in the theta range, whereas a theta peak was not present in age-matched participants. Overall, similar findings were also observed when comparing DS and cognitive-matched groups, suggesting that EEG differences are not explained by delayed cognitive ability.
Open AccessAlterations in aperiodic and periodic EEG activity in young children with Down syndrome
Down syndrome is the most common cause of intellectual disability, yet little is known about the neurobiological pathways leading to cognitive impairments. Electroencephalographic (EEG) measures are commonly used to study neurodevelopmental disorders, but few studies have focused on young children with DS. Here we assess resting state EEG data collected from toddlers/preschoolers with DS (n=29, age 13-48 months old) and compare their aperiodic and periodic EEG features with both age-matched (n=29) and cognitive-matched (n=58) comparison groups. DS participants exhibited significantly reduced aperiodic slope, increased periodic theta power, and decreased alpha peak amplitude. A majority of DS participants displayed a prominent peak in the theta range, whereas a theta peak was not present in age-matched participants. Overall, similar findings were also observed when comparing DS and cognitive-matched groups, suggesting that EEG differences are not explained by delayed cognitive ability.
- 20 December 2023
- Published by Wolters Kluwer Health in Journal of Developmental & Behavioral Pediatrics
- Vol. 45 (1) , e63-e71
Cross-Sectional Analysis of Caregiver-Reported Expressive Language Profiles and Associated Covariates in Individuals with Down Syndrome
Objective: To describe the distribution of expressive language abilities of individuals with Down syndrome (DS) in a clinical sample and characterize demographic, environmental, and medical factors associated with varying expressive language profiles. Methods: Cross-sectional analysis was completed on a sample of 345 individuals with DS between the ages of 4 and 22 years who were enrolled into a longitudinal clinical database between March 2018 and August 2021. Expressive language-related items on a standardized caregiver-reported questionnaire assessing domains of functioning in neurodevelopmental disorders were used to conduct latent variable modeling and determine caregiver-reported expressive language (CREL) classes across the sample. Linear regression was used to explore associations between CREL classes and predictor variables. Results: Latent variable modeling revealed 3 distinct classes of CREL abilities representing higher, middle, and lower CREL. Individuals in the lower CREL class were more likely to be female, to use sign language or visual communication systems, have reduced pronunciation, attend private or residential school, and to be in a substantially separate classroom. Membership was not predicted by complex medical histories or co-occurring neurodevelopmental diagnoses. Conclusion: Caregiver-reported expressive language abilities in a cohort of individuals with DS were variable, with most of the individuals belonging to higher or middle CREL classes, relative to one another. Additional studies are indicated to understand factors that predict higher expressive language ability and explore how to direct services to individuals who are at risk of more profound language delays.
- 20 December 2023
- Published by Wolters Kluwer Health in Journal of Developmental & Behavioral Pediatrics
- Vol. 45 (1) , e63-e71
Cross-Sectional Analysis of Caregiver-Reported Expressive Language Profiles and Associated Covariates in Individuals with Down Syndrome
Objective: To describe the distribution of expressive language abilities of individuals with Down syndrome (DS) in a clinical sample and characterize demographic, environmental, and medical factors associated with varying expressive language profiles. Methods: Cross-sectional analysis was completed on a sample of 345 individuals with DS between the ages of 4 and 22 years who were enrolled into a longitudinal clinical database between March 2018 and August 2021. Expressive language-related items on a standardized caregiver-reported questionnaire assessing domains of functioning in neurodevelopmental disorders were used to conduct latent variable modeling and determine caregiver-reported expressive language (CREL) classes across the sample. Linear regression was used to explore associations between CREL classes and predictor variables. Results: Latent variable modeling revealed 3 distinct classes of CREL abilities representing higher, middle, and lower CREL. Individuals in the lower CREL class were more likely to be female, to use sign language or visual communication systems, have reduced pronunciation, attend private or residential school, and to be in a substantially separate classroom. Membership was not predicted by complex medical histories or co-occurring neurodevelopmental diagnoses. Conclusion: Caregiver-reported expressive language abilities in a cohort of individuals with DS were variable, with most of the individuals belonging to higher or middle CREL classes, relative to one another. Additional studies are indicated to understand factors that predict higher expressive language ability and explore how to direct services to individuals who are at risk of more profound language delays.